ProQR Therapeutics N.V. Stock
Price
Target price
€1.76
€1.76
-1.460%
-0.026
-1.460%
€3.03
23.05.24 / Tradegate
WKN: A12B97 / Symbol: PRQR / Name: ProQR / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
ProQR Therapeutics N.V. Stock
We can see a decrease in the price for ProQR Therapeutics N.V.. Compared to yesterday it has lost -€0.026 (-1.460%).
With 8 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 3 € shows a very positive potential of 70.65% compared to the current price of 1.76 € for ProQR Therapeutics N.V..
For the coming years our community has positive and negative things to say abot the ProQR Therapeutics N.V. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Company culture" there were negative voices in the community.
Pros and Cons of ProQR Therapeutics N.V. in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
S********** s********
Cons
?
C******** o* t** e**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of ProQR Therapeutics N.V. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| ProQR Therapeutics N.V. | -1.460% | -0.114% | -7.082% | 0.285% | -1.788% | -66.830% | - |
| Pharming Group | 0.180% | -3.788% | -9.236% | -30.338% | -20.395% | -18.186% | 8.618% |
| Evolus Inc | -5.830% | 2.564% | 13.208% | 34.078% | 32.597% | 61.074% | - |
| Ardelyx Inc. | -2.470% | -3.853% | 15.454% | 108.097% | 19.170% | 20.842% | - |
Comments
ProQR Therapeutics (NASDAQ: PRQR) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Ratings data for PRQR provided by MarketBeat
ProQR Therapeutics (NASDAQ: PRQR) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $2.50 price target on the stock.
Show more
Ratings data for PRQR provided by MarketBeat
ProQR Therapeutics (NASDAQ: PRQR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Show more
Ratings data for PRQR provided by MarketBeat
